Novel Drug Treatment Shows Improved Cognition in a Phase 3 Cli...
BARCELONA, Spain, Oct. 25, 2018 /PRNewswire-AsiaNet/ -- -- Green Valley Pharmaceutical Company has submitted New Drug Applications and Market Authorization to China Food and Drug Administration (CFDA) for Sodium Oligomannurarate (GV-971) Green Valley Pharmaceutical Co., Ltd. (Headquarter: Shanghai)...
Read more https://view-release/?pr-id=75946